We are live on ! Find out more
RMCM

Reynders McVeigh Capital Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$1.76B
AUM Growth
+$23.6M
Cap. Flow
-$62.2M
Cap. Flow %
-3.54%
Top 10 Hldgs %
42.05%
Holding
203
New
5
Increased
64
Reduced
91
Closed
5

Top Buys

Rank Stock Value
1
RELX icon
RELX
RELX
+$15.2M
2
ULS icon
UL Solutions
ULS
+$8.94M
3
MKC icon
McCormick & Company Non-Voting
MKC
+$6.36M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$5.15M
5
ALC icon
Alcon
ALC
+$5.06M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$57.6M
2
NKE icon
Nike
NKE
+$23.5M
3
CVS icon
CVS Health
CVS
+$12.4M
4
CNI icon
Canadian National Railway
CNI
+$10.5M
5
NVDA icon
NVIDIA
NVDA
+$6.84M

Sector Composition

Rank Sector Weight
1 Technology 34.37%
2 Healthcare 19.6%
3 Industrials 17.79%
4 Consumer Discretionary 9.2%
5 Communication Services 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IFF icon
201
International Flavors & Fragrances
IFF
$21.6B
-2,335
Closed -$201K
NVO
202
Novo Nordisk
NVO
$202B
-448,673
Closed -$57.6M
STKL
203
DELISTED
SunOpta
STKL
-10,600
Closed -$73K

Similar funds

Reynders McVeigh Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Reynders McVeigh Capital Management held 203 positions worth $1.76B, up 1.4% from $1.74B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Reynders McVeigh Capital Management withdrew a net $62.2M in Q2 2024, closing 5 positions and reducing 91 holdings. Its most notable exit was Novo Nordisk, an estimated $57.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Reynders McVeigh Capital Management opened a new position in UL Solutions worth $9.96M.

  • Reynders McVeigh Capital Management's largest Q2 2024 buy was UL Solutions: 236,062 shares worth $9.96M.
  • Reynders McVeigh Capital Management added most to RELX in Q2 2024, an estimated $15.2M increase.
  • Reynders McVeigh Capital Management's biggest Q2 2024 reduction was Nike, cutting an estimated $23.5M.
  • Reynders McVeigh Capital Management fully exited Novo Nordisk in Q2 2024, selling an estimated $57.6M.
  • Reynders McVeigh Capital Management's ten largest holdings make up 42% of its $1.76B portfolio in Q2 2024.
  • Reynders McVeigh Capital Management opened 5 new positions and closed 5 in Q2 2024.
  • Reynders McVeigh Capital Management's portfolio value rose 1.4% quarter-over-quarter to $1.76B.

Based on Reynders McVeigh Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.